Recall Record

Sunnyvale, CA, United States

Cepheid recalls

6 recalls recorded since 2018, most recently on 5 November 2025. 5 are listed as ongoing. Status and classification are as published by the FDA.

Recalls6
Ongoing (FDA)5
Terminated or completed1
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
5 November 2025
Reason
Product testing did not meet expected stability criteria.
Distribution
US Nationwide distribution and Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall number
Z-0724-2026

Ongoing Class II Medical devices

Recall started
30 October 2025
Reason
Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.
Distribution
US: AL AR AZ CA CO FL GA IA IL KS KY LA MD ME MI MN MO NC NE NH NJ NY OH PA RI TX VA WA WI OUS: Algeria Armenia Australia Austria Bahrain Bangladesh Belgium Brazil Burkina Faso Cambodia Canada Canary islands Chile Colombia Cyprus Czech Republic Dem. Rep. Congo Djibouti Dominican Rep. Ecuador El Sal
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0960-2026, Z-0959-2026

Ongoing Class II Medical devices

Recall started
6 August 2025
Reason
As a result of Post-Market half-time stability testing, false negative test result was observed for a positive sample type.
Distribution
U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NV, NY, OH, OK, OR, PA, PR, SC, TN, TX, UT, VA, WA, WI, WV, and WY.
Initiated
Voluntary: Firm initiated
Recall number
Z-0414-2026

Ongoing Class II Medical devices

Recall started
20 June 2024
Reason
Specimen collection device may leak after the patient sample swabs have been inserted into the test tubes, which could result in biohazard exposure, cross contamination causing false positive results for other specimens, and/or delay to test results.
Distribution
Worldwide distribution: US (nationwide): IL, TX, OH, LA, NY, CA, MD, IA, MN, KY, NH, WI, MO, NC, UT, WA, FL, NJ, SC, CO, PA, SD, NE, MT, WV, GA, MA, RI, CT, DE, MS, OK, VA, ID, AZ, OR, MI, IN, TN, AL, KS, ME, AR, NV, HI, AK, NM, WY, VT, ND, DC OUS (foreign) to countries of: Chile, Ireland, Oman, Ni
Initiated
Voluntary: Firm initiated
Recall number
Z-2584-2024

Ongoing Class II Medical devices

Recall started
24 April 2023
Reason
pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.
Distribution
Worldwide distribution - US Nationwide and the countries of Costa Rica, Ireland, Estonia, United Kingdom, Germany, Italy, Greece, Poland, Switzerland, Hong Kong, United Arab Emirates.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0216-2024, Z-0215-2024

Terminated Class II Medical devices

Recall started
9 October 2017
Terminated
13 February 2018
Reason
Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use specimen types. Investigation of the issue also revealed an occasional probability of false negative results which remains consistent with package insert claims.
Distribution
Worldwide Distribution -- USA, Puerto Rico, and Haiti.
Initiated
Voluntary: Firm initiated
Recall number
Z-0592-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.